Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.
about
VEGF-Trap: a VEGF blocker with potent antitumor effects.Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortalityMedical treatment for gastro-entero-pancreatic neuroendocrine tumoursCoronary collateral growth--back to the futureExcess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaEndogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptorsHypothesis: primary antiangiogenic method proposed to treat early stage breast cancerADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy.Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice.Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF.Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injuryAntitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors.Role of VEGF and tissue hypoxia in patterning of neural and vascular cells recruited to the embryonic heartActivated STAT3 is a mediator and biomarker of VEGF endothelial activationVEGF signaling has distinct spatiotemporal roles during heart valve development.Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in miceGene therapy in pancreatic cancer.Gene therapy for malignant liver disease.Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases.Cellular actions and signaling by endostatin.Therapies directed at vascular endothelial growth factor.Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis)Delivery of endostatin in experimental cancer therapy.Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overloadThe merits of vascular targeting for gynecologic malignancies.Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1.Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.Regression of established tumors and metastases by potent vascular endothelial growth factor blockade.Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models.Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases.TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis.Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in miceMice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodiesRecombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice.Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigationeNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype.Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia.Progress report on the potential of angiogenesis inhibitors for neuro-oncology.Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.
P2860
Q24535043-B42A48B5-E574-4297-AC8E-B594A85B4D90Q24676668-C7D8C77C-E297-4BC5-83E9-1B6FA71D3E61Q26751659-5E1A0264-4CD6-40B6-979F-A3B8F1159B3CQ28658320-C41520E3-7B07-41F5-915F-CB5F3D5CB347Q29615916-16C02C59-0800-4032-9E2C-87405C19C998Q33382103-FDAD499D-BDC6-41D9-AD36-FF31F4C0E88BQ33398689-29216697-5628-4E46-ACAD-9CE507D51779Q33423350-D7CDB770-1A52-4DCF-A848-48A6043B4BABQ33517124-75F54D41-8B7E-48FE-9BFA-9A235A721EF3Q33769835-F46363CB-F7E5-4C9B-AEC0-4990557A52FEQ33855218-4EBDD81D-4425-4FEF-ACBB-549DB0DFF417Q34068188-DB5DF57D-82D5-4F3C-8499-1A0F35B2A113Q34079075-4590C6C6-C66B-4C8D-B15C-85F205518453Q34099797-1685BFB4-D033-449B-B607-A890968E0D79Q34216642-9288A575-659F-42A8-8F5F-22137DF3B8DAQ34245416-AF8F4E46-28DD-466B-A555-171BC2E74856Q34302954-624C2825-B6FB-4B86-9A88-5E8E43E2A4D7Q34534279-A78A9A09-F040-4CB1-8AAF-52B8B6EA6190Q34658699-4B8A6EDD-A080-428B-8013-33C3B1E85273Q35008096-F186E6D5-E3E2-410D-A12A-3DAE12F8F674Q35011885-9FF0F9EA-51AD-4870-AE90-7311EDA1EBA2Q35016867-024E1D1D-552F-43D2-87BB-320B89F5DFD2Q35092178-860411C6-1FAA-4370-BB27-D679EB4B0BD0Q35095396-4F2E7587-4B58-4B3F-87E4-A94F784816B5Q35116734-593C7803-8528-4B6D-89D5-72040B34883CQ35122385-56BBAE95-8F34-432E-8A01-14F5C55B674CQ35133764-9AF5E881-9342-404A-B40C-9CA982C8E4DCQ35146833-296437FB-AF1F-493D-BD74-9CB0E53BDEF1Q35163538-B2618D98-E10B-4AD9-A6C7-B95802487A93Q35193397-8ECDF0F8-E767-478C-944A-3A54DF6F42DCQ35212402-DBB6AC73-26E2-4E17-A72B-61E3D3212021Q35622461-A6D5E732-D3E2-404A-ACDD-0434F015F81CQ35640579-4D6228A2-8AA6-4E29-9BC8-19EB052BB680Q35652113-D56F6837-6CBA-41E8-9C0D-112CECCA079DQ35683468-81CF459D-6571-4F5D-BF77-3BDC14DA7BFCQ35695799-8E8E1D35-D4E7-4D58-816F-3572474FE19EQ35853296-2F927915-37B4-4CAA-92EF-44589E070907Q35871466-47D75559-653F-418B-8BEC-510CADFA2C69Q35964419-4166EA7F-DF7D-484F-889C-BEBF09FA6205Q35975055-99A60FF3-CA28-4DA5-B1E9-221792BC5598
P2860
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Comparative evaluation of the ...... ns delivered by gene transfer.
@ast
Comparative evaluation of the ...... ns delivered by gene transfer.
@en
type
label
Comparative evaluation of the ...... ns delivered by gene transfer.
@ast
Comparative evaluation of the ...... ns delivered by gene transfer.
@en
prefLabel
Comparative evaluation of the ...... ns delivered by gene transfer.
@ast
Comparative evaluation of the ...... ns delivered by gene transfer.
@en
P2093
P2860
P356
P1476
Comparative evaluation of the ...... ns delivered by gene transfer.
@en
P2093
Christofferson R
Kamihara J
Mulligan RC
Swearingen RA
P2860
P304
P356
10.1073/PNAS.081615298
P407
P577
2001-03-27T00:00:00Z